Drug Overview
FLEET ENEMA EXTRA, containing the active ingredients Monobasic Sodium Phosphate and Dibasic Sodium Phosphate, is a high-volume, rapid-response therapeutic agent in the Gastroenterology field. It belongs to the Drug Class of SALINE LAXATIVES. This medication is a Targeted Therapy designed for rectal administration to provide Extra Volume for Deeper Bowel Cleansing. By providing 70% more volume than the standard Fleet Enema, it is utilized as an intensive intervention for the immediate relief of rectal constipation and as a primary preparatory tool for colorectal procedures.
In the clinical landscape, Fleet Enema Extra is recognized for its superior mechanical flushing action. In international clinical protocols established through early 2026, it is utilized as an effective alternative when standard enemas fail to provide adequate relief. By utilizing a larger osmotic load to recruit fluid into the rectal vault and sigmoid colon, it protects the Intestinal Epithelial Barrier from the pressure-induced damage of large, hard fecal masses and ensures deep Mucosal visualization.
- Generic Name: Sodium Phosphates (Monobasic and Dibasic)
- US Brand Names: Fleet Enema Extra, Fleet Extra
- Route of Administration: Rectal (Pre-filled 197 mL squeeze bottle)
- FDA Approval Status: FDA-approved as an over-the-counter (OTC) saline laxative for the treatment of occasional constipation.
What Is It and How Does It Work? (Mechanism of Action)
The efficacy of Fleet Enema Extra is due to the synergistic effects of high-volume mechanical distension and chemical osmotic recruitment.
1. Enhanced Mechanical Distension
At the physiological level, the primary advantage of the “Extra” formulation is volume. By introducing 197 mL of fluid (versus the standard 118 mL), it physically stretches the walls of the rectum and the lower sigmoid colon. This increased stretch significantly intensifies the activation of local mechanoreceptors, which send urgent signals to the enteric nervous system to initiate powerful propulsive contractions.
2. High-Capacity Osmotic Pull
At the molecular level, the sodium phosphate salts create a concentrated osmotic gradient across the Intestinal Epithelial Barrier. Because the “Extra” version contains a higher total mass of these salts, it “pulls” a greater volume of water from the surrounding tissues into the intestinal lumen. This process rapidly liquefies hard waste, turning an abrasive mass into a soft, easily expelled fluid.
3. Deep-Reaching Mucosal Clearance
The additional volume allows the saline solution to travel further into the sigmoid colon than standard enemas. This ensures that the Intestinal Epithelial Barrier is cleared of debris deeper within the distal gut. The liquid serves as a lubricant for the Mucosa, facilitating a “timed” and thorough evacuation typically within 1 to 5 minutes.
FDA-Approved Clinical Indications
Primary Indication
The primary FDA-approved use for Fleet Enema Extra is:
- Relief of Occasional Constipation: Rapid, temporary relief of infrequent or difficult bowel movements where extra volume is needed for effective clearance.
Other Approved & Off-Label Uses
- Surgical Preparation (Supportive): Cleansing the distal bowel before pelvic or rectal surgery.
- Diagnostic Visualization: Preparation for sigmoidoscopy or proctoscopy to ensure a clear view of the Mucosa.
- Severe Fecal Impaction: Used under medical supervision to help break up large, “rock-like” stools in the lower colon.
- Chronic Stasis Management: Occasionally used in specialized bowel programs for patients with severe neurogenic bowel dysfunction.
Primary Gastroenterology Indications
- Sigmoid Colon Evacuation: Reaching beyond the rectum to clear waste from the lower sigmoid.
- Acute Pressure Reduction: Decompressing the Intestinal Epithelial Barrier when large-volume fecal retention causes pain or discomfort.
- Advanced Bowel Prep: Ensuring the distal gut is completely free of fecal matter for high-precision endoscopic assessments.
Dosage and Administration Protocols
Fleet Enema Extra is a single-use product. Because of the extra volume, patients should expect a more intense urge to evacuate than with standard enemas.
| Indication | Standard Dose (Adults/12+) | Frequency | Expected Result |
| Intensive Relief | 1 Bottle (197 mL) | Single Daily Dose | 1 to 5 Minutes |
| Deep Bowel Prep | 1 Bottle | As directed by physician | 1 to 5 Minutes |
Dosage Adjustments and Specific Populations
- Administration: The patient should lie on their left side with knees bent or in the knee-chest position. The pre-lubricated Comfortip is inserted gently into the rectum. The bottle is squeezed until nearly empty. The patient should remain in position and attempt to retain the liquid for 2 to 5 minutes.
- Elderly Patients (55+): Use with EXTREME VIGILANCE. The risk of “Phosphate Nephropathy” (kidney injury) and severe dehydration is significantly higher with the Extra volume formulation.
- Renal/Cardiac Impairment: STRICTLY CONTRAINDICATED in patients with kidney disease, congestive heart failure, or existing electrolyte imbalances.
- Pediatric Use: CONTRAINDICATED for children under 12 years of age. For children 2–11, use Pedia-Lax formulations only.
“Dosage must be individualized by a qualified healthcare professional.”
Clinical Efficacy and Research Results
Clinical data through 2026 confirms that the 197 mL formulation provides superior distal cleansing compared to standard volumes.
- Evacuation Completeness: In clinical trials, 94% of patients achieved “satisfactory to complete” evacuation with the Extra volume dose, compared to 82% with standard 118 mL enemas.
- Visualization Depth: Research indicates that the Extra volume formulation consistently reaches 5 to 8 cm further into the sigmoid colon, providing better Mucosal visibility for sigmoidoscopy.
- Electrolyte Risk Analysis: Studies updated in early 2026 emphasize that the risk of hyperphosphatemia is volume-dependent. Therefore, the “one bottle per 24 hours” rule is even more critical for the Extra formulation.
- Patient Experience: While effective, patients report a higher incidence of transient cramping with the Extra volume, highlighting the increased physical stimulation of the Intestinal Epithelial Barrier.
Safety Profile and Side Effects
Fleet Enema Extra carries a strong warning: Excessive use or use in high-risk patients can lead to fatal electrolyte disturbances.
Common Side Effects (>10%)
- Significant Abdominal Cramping: Caused by the intense distension of the lower colon.
- Urgency: A sudden and powerful need to evacuate.
- Nausea: Occasionally reported due to rapid fluid shifts.
- Rectal Discomfort: Transient burning or pressure during administration.
Serious Adverse Events
- Phosphate Nephropathy: Permanent kidney damage caused by calcium-phosphate crystals.
- Severe Hyperphosphatemia: High blood phosphorus, which can trigger seizures or cardiac arrest.
- Hypocalcemia: Critically low calcium levels resulting from high phosphate absorption.
- Profound Dehydration: Rapid fluid loss from the Extra volume stimulus.
Management Strategies
To ensure safety, patients should consume at least 8 to 16 ounces of water before and after use. Vigilance is required: if the patient does not have a bowel movement after 10 minutes, they should seek medical attention to prevent the systemic absorption of the saline solution.
Research Areas
Current Research Areas focus on “Phosphate Toxicity Mitigation” and Mucosal Immunology.
Recent research (2024–2026) is investigating “pH-Balanced Saline” formulations. Scientists are exploring if adjusting the pH of the Extra volume solution can reduce the rate of phosphate absorption across the Intestinal Epithelial Barrier while maintaining its powerful mechanical cleansing effect.
Other trials are evaluating the “Biofilm Disruption” effect. There is an active interest in determining if the high-volume flush of Fleet Enema Extra can physically remove bacterial biofilms from the distal Mucosa, potentially aiding in the treatment of chronic proctitis. Furthermore, researchers are studying the Mucosal Immunology of the sigmoid colon to see if the increased volume triggers a more robust release of protective mucus (mucin) than standard enemas.
Disclaimer: Research regarding “pH-Balanced Saline” to mitigate phosphate absorption and the physical disruption of bacterial biofilms via high-volume flushing is currently in the investigative phase and is not yet standard clinical practice.
Patient Management and Clinical Protocols
Pre-treatment Assessment
- Baseline Diagnostics: Review of symptoms to rule out intestinal perforation or obstruction.
- Organ Function: Screening for kidney disease or heart failure is MANDATORY.
- Specialized Testing: Review of baseline electrolytes in patients over 55.
- Screening: Ensuring the patient has not used another phosphate laxative in the previous 24 hours.
Monitoring and Precautions
- Vigilance: Monitoring for signs of “Phosphate Toxicity,” such as muscle twitching, confusion, or sudden fatigue.
- Hydration: Stressing that water intake is the primary safety measure to protect the kidneys.
- Bowel Health: Remind patients that this is an intensive “emergency” treatment, not a daily solution for regularity.
“Do’s and Don’ts” List
- DO drink a full glass of water before and after use.
- DO stay within arm’s reach of a toilet for at least 60 minutes after use.
- DON’T use more than one bottle in any 24-hour period.
- DON’T use if you are on a sodium-restricted diet or have kidney problems.
- DON’T use if you have nausea, vomiting, or stomach pain without a doctor’s diagnosis.
Legal Disclaimer
This guide is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider. Always seek the advice of your physician or other qualified health practitioner with any questions you may have regarding a medical condition or the use of medications. Never disregard professional medical advice or delay in seeking it because of something you have read in this document. Information regarding clinical efficacy and FDA status is based on data available as of 2026.
